SEPTInvestingStart Free

BBOT EFFECT: SEC filing

BridgeBio Oncology Therapeutics, Inc.

Filed with the SEC on · accession 9999999995-26-002939

BBOT filed a EFFECT (effect) with the SEC on Sep 10, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -18.3% by the first close after the filing.

Summary of the filing

BridgeBio Oncology Therapeutics, Inc. filed an EFFECT notice with the SEC, indicating that a previously filed registration statement has become effective.

For details, click here →

Key details

FilerBridgeBio Oncology Therapeutics, Inc.

How BBOT stock reacted

Close before

$6.75

Sep 9, 2026

First close after

-18.28%

$5.52

5 trading days

-29.53%

$4.76

Since filing

-67.88%

$2.17

✦ Ask GOAX AI about this filing — what it means for BBOT, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for BBOT?

Click here

Frequently asked questions

What did BBOT file with the SEC on Sep 10, 2026?

BBOT filed a EFFECT (SEC filing). BridgeBio Oncology Therapeutics, Inc. filed an EFFECT notice with the SEC, indicating that a previously filed registration statement has become effective.

How do I read a EFFECT?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A EFFECT (effect): A report the company filed with the SEC (the US market regulator).

How did BBOT stock react to this filing?

BBOT closed at $6.75 before the filing and $5.52 on Sep 10, 2026 (-18.28%). Five trading days later: $4.76 (-29.53%).

Other BBOT SEC filings

Get alerts when BBOT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
BBOT overviewBBOT analysisBBOT newsLatest SEC filings